Differential Regulation of BAFF Expression and NET-Associated Responses in Neutrophils from Patients with Systemic Lupus Erythematosus
Antioxidants · 19.11.2026 · 15 (11) · 1507
DOI: 10.3390/antiox15111507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 19.11.2026. Verfasst von Zirui Zeng und 10 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant-in-Aid for Challenging Research.
Abstract (Originalsprache)
Neutrophils are increasingly recognized as functionally heterogeneous regulators of inflammation in systemic lupus erythematosus (SLE), yet whether their major effector responses represent coordinated functions or distinct activation programs remains unclear. In the present study, we examined B-cell activating factor (BAFF) expression, neutrophil extracellular trap (NET)-associated responses, reactive oxygen species (ROS) production, and selected intracellular signaling molecules in density-separated neutrophil and peripheral blood mononuclear cell (PBMC) fractions from healthy donors and patients with SLE. Type I interferon (IFN-I) preferentially induced BAFF expression, whereas Phorbol 12-myristate 13-acetate (PMA) markedly induced NET-associated extracellular dsDNA release, indicating different stimulus requirements. Confocal microscopy showed intracellular BAFF accumulation following IFNα stimulation and altered BAFF localization after subsequent PMA stimulation. Pharmacological analyses showed that ROS scavenging attenuated IFNα-induced BAFF mRNA expression, whereas diphenyleneiodonium chloride (DPI) reduced PMA-induced ROS production and extracellular dsDNA release. MEK inhibition reduced ROS production, but its effect on extracellular dsDNA release was not statistically significant. Furthermore, serum BAFF (sBAFF) concentrations, NET-forming capacity, ROS production, and clinical parameters showed no consistent pattern of associations across patients with SLE, although exploratory PAD4-based stratification suggested possible subgroup-specific relationships. Collectively, our findings indicate that BAFF expression and NET-associated responses differ in their stimulus requirements and pharmacological sensitivities. These findings provide a basis for further investigation of functional neutrophil heterogeneity in SLE and highlight the need for single-cell and mechanistic studies to clarify the relationship between BAFF expression and NET-associated responses.
Förderung
- Grant-in-Aid for Challenging Research
Zitieren
APA
Zeng, Z., Yoshida, Y., Wang, D., Ohkubo, N., Shimizu, S., Sonomoto, K., Yamagata, K., Kubo, S., Iwata, S., Tanaka, Y., & Nakayamada, S. (2026). Differential Regulation of BAFF Expression and NET-Associated Responses in Neutrophils from Patients with Systemic Lupus Erythematosus. Antioxidants, 15(11), 1507. https://doi.org/10.3390/antiox15111507
Vancouver
Zeng Z, Yoshida Y, Wang D, Ohkubo N, Shimizu S, Sonomoto K, et al. Differential Regulation of BAFF Expression and NET-Associated Responses in Neutrophils from Patients with Systemic Lupus Erythematosus. Antioxidants. 2026;15(11):1507. doi:10.3390/antiox15111507
BibTeX
@article{Zeng2026,
author = {Zeng, Zirui and Yoshida, Yasuhiro and Wang, Duo and Ohkubo, Naoaki and Shimizu, Shoichi and Sonomoto, Koshiro and Yamagata, Kaoru and Kubo, Satoshi and Iwata, Shigeru and Tanaka, Yoshiya and Nakayamada, Shingo},
title = {Differential Regulation of BAFF Expression and NET-Associated Responses in Neutrophils from Patients with Systemic Lupus Erythematosus},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {11},
pages = {1507},
doi = {10.3390/antiox15111507}
}
EUVIMED